Drugs / Fecal Microbial Transplantation
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03772899 | Mar 2019 → Sep 2021 overdue | melanoma | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Active not recruiting | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT07509346 | Jun 2026 → May 2029 expected | acute cholangitis | Puerta de Hierro University Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal Microbial Transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03772899 ↗ |
| Known as | FMT | “Patients with recurrent acute cholangitis will receive FMT” NCT07509346 ↗ |